These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 20690710

  • 1. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.
    Torrent M, Odorizzi F, Nogués MV, Boix E.
    Biomacromolecules; 2010 Aug 09; 11(8):1983-90. PubMed ID: 20690710
    [Abstract] [Full Text] [Related]

  • 2. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D, Moussaoui M, Carreras E, Torrent M, Nogués V, Boix E.
    Biochimie; 2011 Feb 09; 93(2):331-8. PubMed ID: 20951760
    [Abstract] [Full Text] [Related]

  • 3. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
    Torrent M, Navarro S, Moussaoui M, Nogués MV, Boix E.
    Biochemistry; 2008 Mar 18; 47(11):3544-55. PubMed ID: 18293932
    [Abstract] [Full Text] [Related]

  • 4. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E, Mossuto MF, Polverino de Laureto P, Dumoulin M, Dobson CM, Fontana A.
    J Mol Biol; 2006 Aug 18; 361(3):551-61. PubMed ID: 16859705
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M, de la Torre BG, Nogués VM, Andreu D, Boix E.
    Biochem J; 2009 Jul 15; 421(3):425-34. PubMed ID: 19450231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A, Schmauder A, Tenidis K.
    J Mol Biol; 2002 Jan 18; 315(3):339-50. PubMed ID: 11786016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro characterization of lactoferrin aggregation and amyloid formation.
    Nilsson MR, Dobson CM.
    Biochemistry; 2003 Jan 21; 42(2):375-82. PubMed ID: 12525164
    [Abstract] [Full Text] [Related]

  • 13. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
    Pulido D, Moussaoui M, Nogués MV, Torrent M, Boix E.
    FEBS J; 2013 Nov 21; 280(22):5841-52. PubMed ID: 23992292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intramolecular charge interactions as a tool to control the coiled-coil-to-amyloid transformation.
    Pagel K, Wagner SC, Rezaei Araghi R, von Berlepsch H, Böttcher C, Koksch B.
    Chemistry; 2008 Nov 21; 14(36):11442-51. PubMed ID: 19016556
    [Abstract] [Full Text] [Related]

  • 18. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
    Nilsson MR, Raleigh DP.
    J Mol Biol; 1999 Dec 17; 294(5):1375-85. PubMed ID: 10600392
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heme binding inhibits the fibrillization of amyloidogenic apomyoglobin and determines lack of aggregate cytotoxicity.
    Iannuzzi C, Vilasi S, Portaccio M, Irace G, Sirangelo I.
    Protein Sci; 2007 Mar 17; 16(3):507-16. PubMed ID: 17242379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.